Table 3.
Results of sensitivity analysis.
| Outcomes | Excluded RCTs | Remaining RCTs | WMD | 95% CI | p | p; I2 | Effect model |
|---|---|---|---|---|---|---|---|
| QUICKI | Salden et al., 2016 | 3 | 0.01 | -0.00 to 0.02 | 0.065 | 0.801; 0.0% | FE |
| LDL-C | Cicero et al., 2019; Davison et al., 2008 | 20 | -0.02 | -0.04 to 0.00 | 0.100 | 0.676; 0.0% | FE |
| DBP | Bogdanski et al., 2012 | 14 | -0.57 | -1.56 to 0.43 | 0.264 | 0.147; 28.9% | FE |
RCTs, randomized controlled trials; WMD, weighted mean difference; CI, confidence interval; QUICKI, quantitative insulin sensitivity check index; LDL-C, low-density lipoprotein cholesterol; DBP, diastolic blood pressure; FE, fixed-effects model.